Autoinflammatory Syndromes: Diagnosis, Symptoms, and Treatment
Understanding autoinflammatory syndromes: genetic disorders of innate immunity causing recurrent fevers, rashes, and organ inflammation.
Autoinflammatory syndromes are a group of genetic disorders characterized by dysregulation of the innate immune system, leading to recurrent episodes of sterile inflammation without identifiable external triggers. These conditions typically present with periodic fevers, skin eruptions, serositis, arthritis, and other systemic symptoms.
What are autoinflammatory syndromes?
Autoinflammatory diseases arise from mutations in genes controlling inflammasomes, cytokines, or other innate immune components, causing excessive production of pro-inflammatory mediators like IL-1β. Unlike autoimmune diseases, which involve adaptive immunity and autoantibodies, autoinflammatory syndromes feature innate immune hyperactivity without specific antigen recognition.
Clinically, they manifest as unprovoked inflammatory attacks lasting days to weeks, often starting in childhood. Common features include high spiking fevers, evanescent rashes, abdominal pain, chest pain, and arthralgias. Laboratory findings during flares show elevated acute-phase reactants (CRP, ESR) and leukocytosis, normalizing between episodes.
Who gets autoinflammatory syndromes? (Epidemiology)
These are rare monogenic disorders with autosomal dominant or recessive inheritance. Prevalence varies: familial Mediterranean fever (FMF) affects 1:200-1:1000 in Mediterranean populations; cryopyrin-associated periodic syndromes (CAPS) are rarer at 1:1,000,000.
Most onset in infancy or early childhood, though adult-onset cases occur. Ethnic predispositions exist, e.g., FMF in Turks, Armenians, Arabs; hyper-IgD syndrome (HIDS) in Dutch/French. Both sexes are equally affected.
Clinical features
Symptoms are episodic, triggered by stress, infections, or cold, resolving spontaneously or with treatment. Core triad: fever, rash, organ inflammation.
- Fever: High (39-41°C), lasts 1-3 days, recurrent every 4-6 weeks.
- Skin: Urticarial, maculopapular, pustular, or erysipelas-like rashes.
- Joints: Non-erosive arthritis/arthralgia.
- Serosal: Peritonitis, pleuritis, pericarditis.
- Other: Splenomegaly, lymphadenopathy, amyloidosis (complication).
Skin lesions are hallmark, aiding diagnosis: non-pruritic evanescent urticaria in CAPS, erythematous macules in FMF.
Specific autoinflammatory syndromes
Familial Mediterranean Fever (FMF)
Most common, caused by MEFV mutations (pyrin gene). Attacks: 1-3 days, fever, serositis, erysipelas-like leg rash, monoarthritis. Complications: AA amyloidosis.
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
TNFRSF1A mutations. Prolonged attacks (1-3 weeks), migratory myalgia, conjunctivitis, periorbital edema, malar erythema. Skin: centrifugal annular plaques.
Hyperimmunoglobulinemia D with periodic fever syndrome (HIDS/MKD)
MVNK mutations (mevalonate kinase). Attacks from infancy: 3-7 days, cervical lymphadenopathy, abdominal pain, diarrhea, aphthous ulcers, maculopapular rash. Elevated IgD.
Cryopyrin-associated periodic syndromes (CAPS)
NLRP3 spectrum: FCAS (cold-induced urticaria), Muckle-Wells (urticaria, deafness, amyloidosis), NOMID (neonatal rash, arthropathy, chronic meningitis). Evanescent urticaria key.
Deficiency of IL-1 receptor antagonist (DIRA)
IL1RN mutations. Neonatal pustulosis, multifocal osteomyelitis, periostitis. Severe pustular rash.
Pyogenic arthritis, pyoderma gangrenosum, acne (PAPA)
PSTPIP1 mutations. Sterile pyogenic arthritis in childhood, cystic acne, pyoderma gangrenosum in adolescence. Pathergy common.
Majeed syndrome
LPIN2 recessive. Chronic recurrent multifocal osteomyelitis (CRMO), neutrophilic dermatosis (Sweet-like), dyserythropoietic anemia.
Autoinflammatory keratinization diseases (AiKDs)
Group including DITRA (IL36RN), CARD14-mediated pustular psoriasis, pityriasis rubra pilaris. Recurrent hyperkeratotic pustular eruptions.
| Syndrome | Gene | Attack Duration | Key Skin Feature |
|---|---|---|---|
| FMF | MEFV | 1-3 days | Erysipelas-like |
| TRAPS | TNFRSF1A | 1-3 weeks | Annular plaques |
| HIDS | MVNK | 3-7 days | Maculopapular |
| CAPS | NLRP3 | Daily | Urticaria |
| PAPA | PSTPIP1 | Variable | PG, acne |
Diagnosis
Clinical + genetic. Eurofever/PRINTO criteria for monogenic AIDs. During flares: ↑CRP/ESR, anemia, neutrophilia. Genetic panels confirmatory. Amyloidosis screening (SAA, biopsy).
Differential: infections, malignancies, autoimmune (SLE, vasculitis), other periodic fevers.
Histopathology
Skin biopsies show neutrophilic/lymphocytic infiltrates without vasculitis. E.g., CAPS: dermal edema, perivascular neutrophils; PAPA: suppurative folliculitis.
Treatment
Targeted biologics revolutionized management. Colchicine for FMF (prevents attacks, amyloidosis).
- IL-1 blockers: Anakinra (daily), canakinumab (q4-8wks) for CAPS, DIRA, PAPA, HIDS.
- IL-6 inhibitors: Tocilizumab for TRAPS.
- TNF inhibitors: Limited role.
- Others: NSAIDs, steroids for flares; JAK inhibitors emerging.
Early treatment prevents organ damage.
Complications
AA amyloidosis (renal failure), growth retardation, deafness (Muckle-Wells), CNS involvement (NOMID).
Prevention
Prophylactic biologics, trigger avoidance (cold for FCAS). Genetic counseling.
Frequently Asked Questions (FAQs)
What causes autoinflammatory syndromes?
Genetic mutations in innate immunity genes like NLRP3, MEFV, leading to inflammasome overactivation and IL-1 excess.
Are autoinflammatory syndromes curable?
No cure, but biologics control symptoms effectively, preventing flares and complications.
Can adults develop these syndromes?
Primarily childhood onset, but variable penetrance allows adult diagnosis.
Is skin rash always present?
Highly characteristic but not universal; e.g., absent in some FMF attacks.
What is the role of dermatologists?
Crucial for recognizing pathognomonic rashes, prompting genetic testing.
References
- Autoinflammatory Disease — Rheumatology Advisor. 2023. https://www.rheumatologyadvisor.com/ddi/autoinflammatory-disease/
- Autoinflammatory syndromes: A review — Journal of Skin and Sexually Transmitted Diseases. 2022. https://jsstd.org/autoinflammatory-syndromes-a-review/
- Cutaneous Manifestations of Autoinflammatory Diseases — PMC – NIH. 2022-09-26. https://pmc.ncbi.nlm.nih.gov/articles/PMC9524803/
- Spectrum of Genetic Autoinflammatory Diseases Presenting with Skin Signs — Acta Dermato-Venereologica. 2021. https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3427
- Designation of Autoinflammatory Skin Manifestations With Specific Diagnostic Criteria — Frontiers in Immunology. 2020-04-02. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00475/full
- Autoinflammatory syndromes — DermNet NZ. 2023. https://dermnetnz.org/topics/autoinflammatory-syndromes
Similar Articles
Read full bio of Sneha Tete
